|

High-dose Methotrexate (8 gm/m2; HD-MTX) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Wake Forest University Health Sciences1

Indications

  • Leptomeningeal Disease1
  • Metastatic Breast Cancer1
  • Breast Cancer1
  • Cancer1

Baltimore, Maryland1 trial

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Sidney Kimmel Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.